Role of HLA Genes and Innate Immunity in the Phenotypic Variability of COVID-19 (3490)

NCT05711836 COMPLETED

Case-control, prospective retrospective association study of patients infected with SARS-CoV2 and cured by COVID19. Recruited patients were divided into two cohorts (cases: patients with respiratory failure that required hospitalization and ventilatory assistance. Controls: patients who had oligo-asymptomatic forms of COVID19). Patients' blood samples were collected on bibula paper, from which genomic DNA was extracted. Next-generation sequencing of HLA and innate immunity genes was performed on these samples. Genetic risk and protective variants were identified, based on the distribution of allele frequencies in the two cohorts. The aim of the study is to evaluate the role of genes of the HLA system and innate immunity in modulating the host response to SARS-CoV2 infection. The identification of these factors is essential from the perspective of public health (identifying individuals most in need of protection from infection as they are at higher risk of severe forms), basic research (characterization of molecular mechanisms of disease) and therapeutics (through knowledge of basic mechanisms, identify potential therapeutic targets and optimize the protective efficacy of vaccines).

Details

Lead sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status	COMPLETED
Enrolment	720
Start date	Thu Jan 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Sep 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• COVID-19

Interventions

• HLA-genotyping

Countries

Italy